Clinical Trial Update: KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for KN046 in advanced pancreatic ductal adenocarcinoma; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Advanced Pancreatic Ductal Adenocarcinoma | Phase 3 | Status: UNKNOWN